Vivere Oncotherapies
PrivateLast Round
Seed
Jan 13, 2026
Total Funding Raised
$13.21M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vivere Oncotherapies is a biotechnology company developing targeted immunotherapies that activate the immune system to detect and destroy cancer cells in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivere Oncotherapies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vivere Oncotherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 13, 2026 | ||||
| Grant | Sep 5, 2025 |
Key People
Founding team and executive leadership
Vivere Oncotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Seed, Grant |
| California Innovation Fund | Seed, Pre Seed |
| Freeflow Ventures | Seed, Pre Seed |
| Pillar VC | Seed, Pre Seed |
| Berkeley Frontier Fund | Seed, Pre Seed |
| Alumni Ventures | Seed |
| Kerna Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Grew 40% QoQ from 10 to 14 employees.
- Feb 20, 2026
Grew 56% QoQ, from 9 to 14 employees.
Vivere Oncotherapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivere Oncotherapies's valuation, stock price, and market status.